Guideline for Size‑Based Management of Pulmonary Nodules

1. Solid Nodules Larger Than 8 mm

• Consider biopsy or resection for solid nodules > 8 mm when the estimated probability of malignancy is moderate (5–60 %) or higher, taking into account patient risk factors and clinical context. (American College of Chest Physicians guideline) 1, 2, 3
• The 8 mm size threshold marks the point at which active intervention (biopsy or surgical resection) becomes appropriate rather than surveillance alone. (American College of Chest Physicians guideline) 1, 2, 3, 4
• Nonsurgical (percutaneous or bronchoscopic) biopsy is recommended when:
• Surgical biopsy or resection is recommended when:

2. Solid Nodules 8 mm or Smaller

• Nodules ≤ 8 mm are generally managed with CT surveillance rather than immediate biopsy. (American College of Chest Physicians guideline) 1, 3, 6

3. Subsolid Nodules

Part‑Solid Nodules

• Part‑solid nodules > 8 mm in total diameter should undergo early evaluation: CT at 3 months, followed by PET, biopsy, and/or resection if the nodule persists. (American College of Chest Physicians guideline) 7
• A solid component > 6 mm within a part‑solid nodule markedly increases the risk of invasive adenocarcinoma. (American College of Chest Physicians guideline) 8
• Part‑solid nodules > 15 mm should proceed directly to definitive evaluation (biopsy or resection) without an initial surveillance period. (American College of Chest Physicians guideline) 7

Pure Ground‑Glass Nodules

• Ground‑glass nodules ≤ 5 mm do not require further evaluation. (American College of Chest Physicians guideline) 7, 5
• Ground‑glass nodules > 5 mm merit annual CT surveillance for at least three years. (American College of Chest Physicians guideline) 7, 5
• Growing ground‑glass nodules can be safely monitored up to 2 cm without a significant increase in stage progression. (American College of Chest Physicians guideline) 8

4. Technical Considerations for Biopsy

• CT‑guided percutaneous biopsy of nodules ≤ 15 mm achieves a diagnostic accuracy of 67.6 %–90 %. (American College of Radiology guideline) 9

5. Measurement Accuracy and Risk Stratification

• The 8 mm threshold is not absolute: malignancy probability is < 1 % for nodules < 6 mm and 1–2 % for nodules 6–8 mm. (American College of Chest Physicians guideline) 2, 4
• Patient‑specific risk factors (age, smoking history, prior malignancy, nodule morphology such as spiculation, and upper‑lobe location) substantially modify management decisions within each size category. (American College of Chest Physicians guideline) 2
• Nodule measurement should use the average of the longest and shortest axial diameters, rounded to the nearest millimeter. (Radiology Society guideline) 10
• Volumetric measurement thresholds of 100 mm³ (≈ 6 mm) and 250 mm³ (≈ 8 mm) provide more reproducible sizing but depend on software algorithms. (Radiology Society guideline) 10
• Consistent imaging technique and reconstruction parameters are essential for reliable longitudinal follow‑up. (Radiology Society guideline) 10

Guidelines for Lung Nodule Biopsy Based on Size and Imaging Characteristics

Size‑Based Biopsy Thresholds

Diagnostic Performance by Nodule Type

Clinical Decision Algorithm

High‑Probability Malignancy (≥ 60 % pre‑test probability)

Moderate‑Probability Malignancy (5–60 % pre‑test probability) or Need for Anatomic Resection

Pitfalls and Limitations

Safety Considerations (Evidence Not Cited)

(Safety data were mentioned in the source article but lacked specific citations and therefore are omitted from this evidence‑based summary.)